Riboflavin (Vitamin B2) Accumulation Modulates Neuronal Cellular Homeostasis in Typical Brain Development and

Eulália Rebeca Silva-Araújo1,2,3, Eduardo Padrón-Hernández1,3,4, Ana Elisa Toscano5,6,7,8

  • 1Graduate Program in Neuropsychiatry and Behavioral Sciences, Center for Medical Sciences, Federal University of Pernambuco, Recife, Pernambuco, 50670-901, Brazil.

Neurochemical Research
|September 12, 2025
PubMed

Insights

Vitamin B2 (riboflavin) shows promise for brain development and cerebral palsy (CP). High-dose riboflavin supports energy metabolism, reduces oxidative stress, and improves mitochondrial function in preclinical models.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Developmental Biology

Background:

  • The developing brain has high energy demands for oxidative stress regulation and myelination.
  • Early brain insults can lead to mitochondrial dysfunction, potentially causing cerebral palsy (CP).

Purpose of the Study:

  • To investigate the role and effects of high-dose vitamin B2 (riboflavin) in neurodevelopment and cerebral palsy models.

Main Methods:

  • A rodent preclinical study administering high-dose vitamin B2 (100 mg/kg).
  • Analysis of redox homeostasis markers (malondialdehyde, carbonyls, glutathione-S-transferase, superoxide dismutase).
  • Mitochondrial morphometric and ultrastructural analyses, including myelin sheath thickness.

Main Results:

  • Riboflavin accumulated in both healthy and CP brains, supporting neurodevelopment.
  • Riboflavin maintained redox homeostasis and improved mitochondrial biogenesis and structure.
  • Treatment reduced oxidative stress markers and improved myelin sheath integrity in CP models.

Conclusions:

  • Vitamin B2 accumulation is a beneficial mechanism supporting brain energy homeostasis and mitochondrial function.
  • Riboflavin demonstrates potential therapeutic benefits for neurodevelopmental disorders like CP.

Related Concept Videos

Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
2.3K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
Transcriptional Regulation: Riboswitches01:23

Transcriptional Regulation: Riboswitches

Riboswitches are RNA elements that regulate gene expression by altering their secondary structures in response to specific effector molecules. These elements, located in the leader regions of certain mRNAs, act as transcriptional regulators by toggling between alternative conformations to control downstream gene expression. Riboswitch-mediated regulation is a precise mechanism for modulating biosynthetic pathways, as exemplified by the riboflavin biosynthesis pathway in Bacillus...
592
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
834
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
699
The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview
52.4K